Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

Ravimanz Pharmaceuticals

Class 35Status: Under Examination
Trademark Logo
Application Number6953357
Trademark Status
Under Examination
Trademark Class35
Application Date2025-04-12
Proprietor NameKANCHAN SRIVASTAVA
Appropriate OfficeDELHI
StateUTTAR PRADESH
Trademark TypeDEVICE
User DetailsProposed to be used
Agent NameNEWTON REGINALD[25853]
Agent AddressNo 6, Dhanammal Street Spurtank Road Chetpet Chennai - 600031
Goods And Services Details[CLASS : 35] Marketing, Advertising, Wholesale ordering services, Wholesale store services, Online wholesale services, Online retail services, Business management of wholesale and retail outlets, Online advertising and marketing services, Import-export business services, Business management, Wholesale and retail services

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about Ravimanz Pharmaceuticals.

The current status of trademark application 6953357 for Ravimanz Pharmaceuticals is Under Examination.
Ravimanz Pharmaceuticals is registered under trademark class 35.
The proprietor of Ravimanz Pharmaceuticals is KANCHAN SRIVASTAVA.
Trademark application 6953357 for Ravimanz Pharmaceuticals was filed on 2025-04-12.